(PharmaNewsWire.Com, January 17, 2017 ) The digital pathology market is poised to reach USD 679.1 Million by 2021, growing at a CAGR of 12.1% during the forecast period of 2016 to 2021. The growth of the overall market can be contributed to the rising cancer prevalence, increasing tele-consultations, utilization of digital pathology for drug discovery and companion diagnostics, and increasing government and industry player’s initiatives into the pathological services. However, stringent regulatory concerns for primary diagnosis and lack of standard guidelines for digital pathology are likely to hamper the growth of the market.
Request Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=844 This report segments the digital pathology market based on product, type, end user and application. The product segments described in the report are scanner, software, communication system and storage system. The scanner segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the increasing adoption of digital pathology solutions across globe. Software segment is projected to have fastest growth rate of 12.6% in the forecast period, due to availability of user-friendly, analytical and advanced functions for pathology diagnosis.
North America is estimated to account for the largest share of the global digital pathology market. Increasing cancer prevalence, rising demand for quality diagnostics, favorable reimbursement policies, and initiatives undertaken by governments are some of the key factors driving the growth of the market in North America. Europe is expected to account for the second-largest share of the market. A majority of the leading players in the market are pursuing the strategies of new product launches, collaborations, and partnerships.
In the coming years, the digital pathology market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on China, Japan, India and the Rest of Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Factors such as large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the market in this region.
Speak To Our Analyst@ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=844 Prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH (Germany), Ventana Medical Systems, Inc.(U.S.), Hamamatsu Photonics K.K (Japan), 3D Histech Ltd(Hungary)., Philips Healthcare (Netherlands), Apollo Enterprise Imaging Corp.(U.S.), Xifin, Inc.(U.S.), Definiens AG (Germany), Visiopharm A/S (Denmark), Omnyx, LLC.(U.S.), Corista LLC (U.S.).
About MarketsandMarkets
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com
(PharmaNewsWire.Com, January 17, 2017 ) The digital pathology market is poised to reach USD 679.1 Million by 2021, growing at a CAGR of 12.1% during the forecast period of 2016 to 2021. The growth of the overall market can be contributed to the rising cancer prevalence, increasing tele-consultations, utilization of digital pathology for drug discovery and companion diagnostics, and increasing government and industry player’s initiatives into the pathological services. However, stringent regulatory concerns for primary diagnosis and lack of standard guidelines for digital pathology are likely to hamper the growth of the market.
Request Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=844 This report segments the digital pathology market based on product, type, end user and application. The product segments described in the report are scanner, software, communication system and storage system. The scanner segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the increasing adoption of digital pathology solutions across globe. Software segment is projected to have fastest growth rate of 12.6% in the forecast period, due to availability of user-friendly, analytical and advanced functions for pathology diagnosis.
North America is estimated to account for the largest share of the global digital pathology market. Increasing cancer prevalence, rising demand for quality diagnostics, favorable reimbursement policies, and initiatives undertaken by governments are some of the key factors driving the growth of the market in North America. Europe is expected to account for the second-largest share of the market. A majority of the leading players in the market are pursuing the strategies of new product launches, collaborations, and partnerships.
In the coming years, the digital pathology market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on China, Japan, India and the Rest of Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Factors such as large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the market in this region.
Speak To Our Analyst@ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=844 Prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH (Germany), Ventana Medical Systems, Inc.(U.S.), Hamamatsu Photonics K.K (Japan), 3D Histech Ltd(Hungary)., Philips Healthcare (Netherlands), Apollo Enterprise Imaging Corp.(U.S.), Xifin, Inc.(U.S.), Definiens AG (Germany), Visiopharm A/S (Denmark), Omnyx, LLC.(U.S.), Corista LLC (U.S.).
About MarketsandMarkets
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
